Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection
- PMID: 2153430
- DOI: 10.1002/1097-0142(19900201)65:3<492::aid-cncr2820650320>3.0.co;2-c
Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection
Abstract
Kaposi's sarcoma of the gingiva and skin developed in an HIV-negative renal transplant patient while he was receiving cyclosporine therapy. The Kaposi's sarcoma developed shortly after the patient had an acute infection with cytomegalovirus (CMV). Electron microscopy of the tumor's established cell line showed two types of virus-like particles. CMV DNA was identifiable in the cell line whereas infectious CMV could be isolated only after repeated passages (only after 3 months of culture). The other virus could not be identified, but did not appear to be either HIV or papilloma virus. The patient's tumor regressed after the discontinuation of cyclosporine therapy and the recovery from the acute CMV infection.
Similar articles
-
[Kaposi's sarcoma in patients with kidney transplantation].Lijec Vjesn. 1994 Mar-Apr;116(3-4):95-7. Lijec Vjesn. 1994. PMID: 8057746 Croatian.
-
Kaposi's sarcoma in a renal transplant patient receiving cyclosporine.Am J Med Sci. 1987 Sep;294(3):211-3. doi: 10.1097/00000441-198709000-00012. Am J Med Sci. 1987. PMID: 3310638
-
Kaposi's sarcoma in cyclosporine-induced gingival hyperplasia.Am J Kidney Dis. 1988 Apr;11(4):349-52. doi: 10.1016/s0272-6386(88)80142-2. Am J Kidney Dis. 1988. PMID: 3281453
-
Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression?Am J Nephrol. 1992;12(5):384-6. doi: 10.1159/000168478. Am J Nephrol. 1992. PMID: 1489012 Review.
-
Kaposi's sarcoma: a review and recent developments.Clin Bull. 1980;10(2):62-9. Clin Bull. 1980. PMID: 6249516 Review. No abstract available.
Cited by
-
Mapping herpesvirus-driven impacts on the cellular milieu and transcriptional profile of Kaposi sarcoma in patient-derived mouse models.bioRxiv [Preprint]. 2024 Sep 28:2024.09.27.615429. doi: 10.1101/2024.09.27.615429. bioRxiv. 2024. PMID: 39386738 Free PMC article. Preprint.
-
A simple method for rapid cloning of complete herpesvirus genomes.Cell Rep Methods. 2024 Feb 26;4(2):100696. doi: 10.1016/j.crmeth.2024.100696. Epub 2024 Jan 23. Cell Rep Methods. 2024. PMID: 38266652 Free PMC article.
-
Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.J Virol. 2020 Feb 14;94(5):e01791-19. doi: 10.1128/JVI.01791-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31826996 Free PMC article.
-
Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.J Virol. 2016 Sep 12;90(19):8822-41. doi: 10.1128/JVI.01003-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27466416 Free PMC article.
-
MicroRNA-126-3p suppresses cell proliferation by targeting PIK3R2 in Kaposi's sarcoma cells.Oncotarget. 2016 Jun 14;7(24):36614-36621. doi: 10.18632/oncotarget.9311. Oncotarget. 2016. PMID: 27191494 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical